Sat, Feb 28, 2015, 2:51 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Alimera Sciences, Inc. (ALIM) Message Board

  • paultradestoday paultradestoday Jul 19, 2012 10:24 AM Flag

    From here...

    there is a good reference point at $2.91/share since $40 million is now invested at that price. That should provide a bottom. Because they are going it alone, any ramp in price is on hold for 12-18 months. Another catalyst is the FDA official minutes due soon. The meeting was positive but I don't expect any exciting news in the minutes.

    Citi: Mgmt did note that it expects sales & marketing to be
    roughly $18-20M per year once fully ramped. By our initial estimates, we believe year 1 Iluvien EU revs could be about $10M and year 2 about $50-75M.
    Citi is neutral.

    I was looking for them to get bought by a big pharma. Now I will start to reduce my shares on any rise and move on. Still have 33K shares.

5.23-0.05(-0.95%)Feb 27 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.